Clinical Trial Update: Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin [Phase 3]

View source ↗

Summary

Phase 3 trial results show the efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin therapy or the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2018-05-07